TrialThe Lancet. Respiratory medicine2021

Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.

Jordana B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.